Zevra Therapeutics's market cap is currently $548.44M. The company's EPS TTM is $1.21; its P/E ratio is ―; Zevra Therapeutics is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
